Pasithea Therapeutics KTTA
NASDAQ KTTA
$0.50 +0.01 (+2.15%)
As of: Oct 2, 2026 · 1:46 PM EDT

Pasithea Therapeutics (KTTA) Liabilities and Shareholders Equity (2020 - 2026)

Updated

Pasithea Therapeutics' Liabilities and Shareholders Equity came in at $51.71 million for Q2 2026, up 204.0% from $17.01 million a year earlier but down 8.2% from the prior quarter.

Analysis

Pasithea Therapeutics (KTTA) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

At the end of FY2025, Pasithea Therapeutics' Liabilities and Shareholders Equity was $60.24 million, up 275.0% from FY2024.

  • Liabilities and Shareholders Equity carries a five-year compound annual growth rate of 200.0% (FY2020 to FY2025).
  • Going back by year, Liabilities and Shareholders Equity was $16.06 million in FY2024 (-38.5%), $26.12 million in FY2023 (-42.2%), $45.18 million in FY2022 (-15.3%) and $53.32 million in FY2021.
  • The five-year range for quarterly Liabilities and Shareholders Equity is $13.63 million (Q3 2025) to $60.24 million (Q4 2025).
  • Year-over-year, Liabilities and Shareholders Equity has increased for three consecutive quarters, with growth averaging 77.6% over the last eight quarters.
  • The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q1 2026 (growth of 284.4%), and the weakest in Q2 2024 (a decline of 53.7%).
  • Business Quant data shows KTTA's Liabilities and Shareholders Equity at $56.35 million (Q1 2026), $60.24 million (Q4 2025) and $13.63 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Pasithea Therapeutics 16.37 Mn 16.37 Mn - 51.71 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 51.71 Mn
Mar 31, 2026 56.35 Mn
Dec 31, 2025 60.24 Mn
Sep 30, 2025 13.63 Mn
Jun 30, 2025 17.01 Mn
Mar 31, 2025 14.66 Mn
Dec 31, 2024 16.06 Mn
Sep 30, 2024 18.64 Mn
Jun 30, 2024 17.66 Mn
Mar 31, 2024 22.41 Mn
Dec 31, 2023 26.12 Mn
Sep 30, 2023 30.66 Mn
Jun 30, 2023 38.15 Mn
Mar 31, 2023 42.04 Mn
Dec 31, 2022 45.18 Mn
Sep 30, 2022 49.61 Mn
Jun 30, 2022 53.03 Mn
Mar 31, 2022 51.08 Mn
Dec 31, 2021 53.32 Mn
Sep 30, 2021 21.04 Mn
API Access

Pasithea Therapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=KTTA&period=max&api_key=YOUR_API_KEY